In recent years, digital technologies like big data, artificial intelligence and cloud computing have prompted transformation in many industries. The financial sector has been no exception, ...

DAVENPORT, Iowa, May 01, 2024 (GLOBE NEWSWIRE) -- Les Ottolenghi, a Fortune 500 senior technology and cybersecurity executive, has joined Lee Enterprises, Incorporated (LEE), as Chief Transformation ...

CHICAGO, May 22, 2025 /PRNewswire/ -- Digital transformation and on-the-job training is on the docket for commercial P&C insurance organizations in 2025. In this year's Convr Insurance Talent and Tech ...

Raised full-year 2025 revenue guidance from $115 million-$125 million to $122 million-$126 million. Gaeta stated, "We are very confident in our outlook and yet intend to maintain a level of ...

COLUMBUS, Ohio, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Avaap, a premier technology and advisory consulting partner, today announced the launch of its Workday Diversified Industries consulting practice.

The proceeds of this financing are expected to support Immunic's strategic transition from a research and development (R&D)-focused company into a fully integrated commercial entity. In the coming ...

Commercial printers are heading into 2026 with both unprecedented opportunity and unprecedented pressure. Inflation, tariffs, and labor shortages continue to squeeze profitability, yet the industry is ...

It is 2025, yet commercial real estate brokers still work like characters from "Mad Men," hunched over desks, manually piecing together marketing materials and spending more than 30 hours weekly on ...

Gene Zhang, Chief Executive Officer of Huawei South Africa Enterprise Business. Huawei East London Commercial Connect 2025 brought together industry leaders, government representatives and technology ...

Les Ottolenghi, a Fortune 500 senior technology and cybersecurity executive, has joined Lee Enterprises as Chief Transformation and Commercial Officer. In a press release Wednesday, Kevin Mowbray, Lee ...

– Upfront Proceeds of USD 200 Million, with Potential for up to USD 200 Million in Additional Proceeds – – Expected to Fund Completion of Phase 3 ENSURE Trials in Relapsing Multiple Sclerosis, ...